Video Experimental Relacionado
Updated: Aug 17, 2026

08:01
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Terapia combinada con anfotericina B y flucytosina en la neumonía por Aspergillus
JAMA
|June 1, 1979
Resumen
El tratamiento de la aspergilosis está mejorando. Una combinación de anfotericina B y flucytosina es prometedora para el tratamiento de la neumonía por Aspergillus, reduciendo potencialmente los efectos secundarios y mejorando las tasas de curación de esta grave infección por hongos.
Área de la Ciencia:
- La micología médica La micología médica.
- Enfermedades infecciosas Enfermedades infecciosas.
- Farmacología Farmacología.
Sus antecedentes:
- La incidencia de la aspergilosis está aumentando a nivel mundial.
- El pronóstico para la aspergilosis invasiva sigue siendo pobre.
- La monoterapia estándar con anfotericina B tiene una eficacia limitada.
Videos de Conceptos Relacionados
Fungal Phylum Ascomycota
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

